Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised ABG Sundal Collier and Carnegie in connection with a capital raising in Xshore
Mandate

Vinge has advised ABG Sundal Collier and Carnegie in connection with a capital raising in Xshore

April 12, 2022 Capital Markets and Public M&A

Vinge has advised ABG Sundal Collier and Carnegie in connection with a capital raising in Xshore of approximately SEK 500 million by way of a directed share issue to several new investors and current shareholders.

Xshore was founded in 2016 by Konrad Bergström with the intention of providing customers with a superior and sustainable user experience and thereby driving the industry to act more sustainably. Xshore has a leading market position and was nominated for Powerboat of the year 2022 in competition with non-electric boats.

Vinge’s team consisted of Dain Hård Nevonen och Linnéa Sellström

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026